AU4842693A - Method for deriving epitopes - Google Patents

Method for deriving epitopes

Info

Publication number
AU4842693A
AU4842693A AU48426/93A AU4842693A AU4842693A AU 4842693 A AU4842693 A AU 4842693A AU 48426/93 A AU48426/93 A AU 48426/93A AU 4842693 A AU4842693 A AU 4842693A AU 4842693 A AU4842693 A AU 4842693A
Authority
AU
Australia
Prior art keywords
epitopes
deriving
deriving epitopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48426/93A
Inventor
Jack D Keene
Daniel J Kenan
Donald E Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of AU4842693A publication Critical patent/AU4842693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU48426/93A 1992-09-11 1993-08-31 Method for deriving epitopes Abandoned AU4842693A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94420892A 1992-09-11 1992-09-11
US944208 1992-09-11
US95669392A 1992-09-30 1992-09-30
US956693 1992-09-30
PCT/US1993/008210 WO1994006934A1 (en) 1992-09-11 1993-08-31 Method for deriving epitopes

Publications (1)

Publication Number Publication Date
AU4842693A true AU4842693A (en) 1994-04-12

Family

ID=27130197

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48426/93A Abandoned AU4842693A (en) 1992-09-11 1993-08-31 Method for deriving epitopes

Country Status (2)

Country Link
AU (1) AU4842693A (en)
WO (1) WO1994006934A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5864026A (en) * 1990-06-11 1999-01-26 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US5789157A (en) * 1990-06-11 1998-08-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US5763566A (en) * 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue SELEX
US6127119A (en) * 1990-06-11 2000-10-03 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US5688935A (en) * 1990-06-11 1997-11-18 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US5750342A (en) * 1990-06-11 1998-05-12 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US5712375A (en) * 1990-06-11 1998-01-27 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
AU732961B2 (en) * 1995-05-03 2001-05-03 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US8815517B2 (en) 1999-12-28 2014-08-26 Ribonomics, Inc. Methods for identifying functionally related genes and drug targets
JP5002105B2 (en) * 1999-12-28 2012-08-15 リボノミックス， インコーポレイテッド Methods for isolation and characterization of endogenous mRNA protein (mRNP) complexes
US7964356B2 (en) 2007-01-16 2011-06-21 Somalogic, Inc. Method for generating aptamers with improved off-rates
US8975026B2 (en) 2007-01-16 2015-03-10 Somalogic, Inc. Method for generating aptamers with improved off-rates
US8703416B2 (en) 2008-07-17 2014-04-22 Somalogic, Inc. Method for purification and identification of sperm cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2763958B2 (en) * 1990-06-11 1998-06-11 ネクスター ファーマスーティカルズ，インコーポレイテッド Nucleic acid ligand

Also Published As

Publication number Publication date
WO1994006934A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
EG19392A (en) Improved method for omprazole symthesis
AU7103191A (en) Method for executing trust-path commands
AU3252289A (en) Method for predictive dialing
AU4615693A (en) Method for access control
AU688337B2 (en) Novel method for preparing ergothioneine
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU3328095A (en) Method for generating curves
AU4842693A (en) Method for deriving epitopes
AU7170394A (en) Selectively-removable indicia-containing surface-coating method
GB2284054B (en) Method for range determination
AU3385693A (en) Determination method
HU9300999D0 (en) Method for producing imidazo-pyridines
ZA947681B (en) Method for preparing 3-aminopyridines from 3-nitro-pyridines
HU9300927D0 (en) Method for hetero-annulation
HU9301934D0 (en) Method for producing heterocyclyl-phenoxy-alkyl-piperidinyl-pyridazines
AU682520B2 (en) TDM method
GB2296556B (en) Method for degreasing-drying objects
AU4261793A (en) Wedge-welding method
AU4142293A (en) Method for HLA-DP typing
HU9301082D0 (en) Method for producing 2-amino-5-methyl-pyridine
AU1618392A (en) Method for the realization of binding elements
AU640603B3 (en) Method
LTIP166A (en) Method for making point
AU5083193A (en) Method for making humanized antibodies
HU9200966D0 (en) Method for producing 4-hydroxy-7-chloro-quinoline